CYTOMX THERAPEUTICS INC. (CTMX) — institutional ownership

186 funds reported holding CYTOMX THERAPEUTICS INC. in their latest 13F filings, worth $844M in total (CUSIP 23284F105).

Largest holders

1. FMR LLC — $123M
2. Kynam Capital Management, LP — $81.4M
3. BlackRock, Inc. (BLK) — $65.8M
4. BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $56.6M
5. STATE STREET CORP (STT, STT-PG) — $44.1M
6. PERCEPTIVE ADVISORS LLC — $39.1M
7. VANGUARD GROUP INC — $36.1M
8. VANGUARD CAPITAL MANAGEMENT LLC — $32.0M
9. Point72 Asset Management, L.P. — $29.3M
10. WELLINGTON MANAGEMENT GROUP LLP — $19.4M

Famous investors holding it

• Two Sigma portfolio (Two Sigma Investments)
• Ken Griffin portfolio (Citadel Advisors)
• Izzy Englander portfolio (Millennium Management)

Insider buying and selling at CYTOMX THERAPEUTICS INC.

Who owns the most CTMX stock?

The largest institutional holders in the latest 13F filings are FMR LLC ($123M), Kynam Capital Management, LP ($81.4M), BlackRock, Inc. (BLK) ($65.8M).

How many funds own CTMX?

186 funds reported holding it, worth $844M in total.